A significant advance in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This essential cancer suppressor protein is frequently disabled in several kinds of cancer, resulting https://userbookmark.com/story21879164/mini-antibodies-revive-tumor-suppressor-p53-a-potential-hope-for-cancer-management